Printer Friendly

DATASCOPE REPORTS NET UP 42 PERCENT IN THIRD QUARTER

 DATASCOPE REPORTS NET UP 42 PERCENT IN THIRD QUARTER
 MONTVALE, N.J., April 21 /PRNewswire/ -- Datascope Corp. (NASDAQ: DSCP) today reported a 42 percent rise in net earnings in the third quarter of fiscal 1992 to $3.47 million from $2.45 million in the comparable period last year, equivalent to $0.21 per share this year against $0.15 per share last year on average shares outstanding of 16.5 million and 15.9 million, respectively, adjusted for the company's 3-for-1 stock split.
 Consolidated sales in the third quarter were $41.1 million, 16 percent above a year ago and the highest quarterly sales in the company's history.
 In the nine-month period ended March 31, 1992, Datascope's net earnings rose 56 percent to $7.54 million on sales of $111.4 million, 16 percent ahead of a year ago. Net earnings per share were $0.46 vs. $0.31 last year.
 The company said its core business, the cardiac assist and patient monitoring divisions, continued to drive sales and earnings growth in the third quarter.
 Shipments of intra-aortic balloon (IAB) catheters showed strong growth, reflecting increasing intervention with IAB treatment and the successful impact of the company's 9.5 FR. sheathless IAB introduced in the first quarter of fiscal 1992. By taking up one-third less space in the artery, the sheathless IAB catheter allows substantially greater blood flow around the catheter, an attribute that is expected to reduce complications in intra-aortic balloon pumping.
 Sales of patient monitors were also strong, the company said, noting that major contributions to growth came from the 3000A multi-function monitor and the new portable PASSPORT(TM) monitor that began shipping in the second quarter and has rapidly become Datascope's fastest growing monitor product. The PASSPORT EL, a new model with a large electro- luminescent screen that provides a wide viewing angle, began shipping this month and is expected to further enhance the PASSPORT'S competitive position.
 On April 13, 1992, the company was notified by the U.S. Food and Drug Administration that the company's Pre-Market Approval application for VasoSeal(TM) submitted on Feb. 3, 1992, was found suitable for filing and, thus, would have a filing date of Feb. 3, 1992.
 VasoSeal, announced by the company in April 1991, is the first device that can rapidly seal the arterial puncture created for coronary and peripheral angioplasty, angiography and other procedures requiring arterial catheterizations. The company estimates more than 4.5 million such procedures were performed throughout the world in 1991 including 3.2 million in the United States.
 Datascope Corp. is a manufacturer of proprietary products for clinical health care markets in interventional cardiology, anesthesiology and cardiovascular and vascular surgery.
 DATASCOPE CORP.
 Summary of Operating Results
 (Unaudited)
 Periods ended Three Months Nine Months
 March 31 1992 1991 1992 1991
 Sales $41,100,000 $35,550,000 $111,400,000 $96,250,000
 Earnings bef.
 taxes 5,184,000 3,553,000 11,448,000 7,173,000
 Taxes 1,711,000 1,101,000 3,903,000 2,339,000
 Net earnings 3,473,000 2,452,000 7,545,000 4,834,000
 Earnings
 per share(A) $0.21 $0.15 $0.46 $0.31
 Average number of
 common and common
 equivalent shares
 outstdg.(A) 16,495,000 15,930,000 16,449,000 15,525,000
 (A) -- Adjusted for 3-for-1 stock split issued to shareholders of record on Dec. 6, 1991, and effective Jan. 3, 1992.
 -0- 4/21/92
 /CONTACT: Murray Pitkowsky, CFO of Datascope, 201-307-5504/
 (DSCP) CO: Datascope Corp. ST: New Jersey IN: HEA SU: ERN


CK -- NY048 -- 0532 04/21/92 10:42 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 21, 1992
Words:605
Previous Article:PEPSI-COLA SAYS "UH-HUH!" TO NUTRASWEET
Next Article:ECOLOGY AND ENVIRONMENT, INC., SELECTED FOR AWARD OF POTENTIAL $25 MILLION CONTRACT


Related Articles
DATASCOPE REPORTS 42 PERCENT RISE IN SECOND QUARTER NET
DATASCOPE REPORTS STRONG OPERATING RESULTS FOR FISCAL 1992
DATASCOPE NET UP 49 PERCENT IN FIRST QUARTER
DATASCOPE NET UP 29 PERCENT IN SECOND QUARTER
DATASCOPE CORP. REPORTS THIRD QUARTER RESULTS
DATASCOPE REPORTS FISCAL 1993 RESULTS
DATASCOPE NET UP 15 PERCENT IN FIRST QUARTER
DATASCOPE NET UP 29% IN THIRD QUARTER
DATASCOPE REPORTS HIGHER THIRD QUARTER RESULTS AND ANTICIPATES NEAR-TERM RESULTS BELOW EARLIER EXPECTATIONS
Datascope Reports Record Third Quarter Results.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters